2017
DOI: 10.18632/aging.101231 View full text |Buy / Rent full text
|
|

Abstract: Cybrid technology was used to replace Leber hereditary optic neuropathy (LHON) causing mitochondrial DNA (mtDNA) mutations from patient-specific fibroblasts with wildtype mtDNA, and mutation-free induced pluripotent stem cells (iPSCs) were generated subsequently. Retinal ganglion cell (RGC) differentiation demonstrates increased cell death in LHON-RGCs and can be rescued in cybrid corrected RGCs.

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance
Select...
0
24
0

Publication Types

Select...

Relationship

0
0

Authors

Journals